Primary gliosarcoma: epidemiology, clinical presentation, management, and survival

Area of Science:

• Neuro-oncology
• Central Nervous System Tumors
• Neurosurgery

Background:

• Gliosarcomas are rare malignant central nervous system tumors.
• Often considered a variant of glioblastoma (GBM), evidence suggests they may be a distinct entity.
• This study presents one of the largest case series of primary gliosarcomas (PGS).

Purpose of the Study:

• To analyze clinical characteristics, treatment outcomes, and survival data for primary gliosarcomas.
• To evaluate the efficacy of adjuvant therapies in improving patient survival.

Main Methods:

• Retrospective analysis of a single-center case series over 14 years.
• Inclusion of data on patient demographics, presenting symptoms, tumor location, and treatment modalities.
• Survival analysis based on age, treatment received (surgery, radiotherapy, chemotherapy), and functional status.

Main Results:

• The study included patients with a mean age of 59 years, predominantly male.
• Common symptoms included balance/mobility issues (61%), headaches (50%), and visual problems (39%).
• Patients under 50 had a survival advantage. Adjuvant radiotherapy and chemo-radiotherapy significantly improved median survival (14 and 30 months, respectively) and one-year survival rates (46% and 77%).

Conclusions:

• Adjuvant chemo-radiotherapy is a critical treatment for primary gliosarcoma patients with good functional status.
• This combined therapy confers a significant survival advantage.
• Further research into the distinct nature and optimal treatment of gliosarcomas is warranted.